Lexology August 22, 2024
Questel

Navigating the complex regulatory compliance landscape in the life sciences sector is a formidable challenge, especially when dealing with medical devices and pharmaceutical translations. The European Union Medical Device Regulation (EUMDR) and In Vitro Diagnostic Regulation (IVDR) have introduced stringent requirements, making it more crucial than ever for companies to avoid common pitfalls. As the Director of Life Sciences Business Development, I have observed how these regulations impact our industry and the vital role of high-quality translation in achieving compliance.

Here, I’ll share ten tips to help you overcome these challenges and ensure your translations meet regulatory standards.

1. Understand the Regulatory Landscape

Before embarking on any translation project, it’s essential to understand the regulatory requirements of the target market...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma / Biotech, Regulations
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Stakeholder Management and Interoperability of Biosimilars
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more
FDA approves first rapid-acting insulin biosimilar for diabetes

Share This Article